Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jun;115(6):913-914.
doi: 10.1007/s12185-022-03349-1. Epub 2022 Apr 12.

Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination

Tohru Inaba  1 , Keita Okumura  2 , Chika Maekura  3 , Ayako Muramatsu  3 , Tsutomu Kobayashi  3 , Junya Kuroda  3 , Yoko Nukui  4
Affiliations
Comment

Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination

Tohru Inaba et al. Int J Hematol. 2022 Jun.

Erratum in

No abstract available

Keywords: Anti-CD20 monoclonal antibody therapy; Anti-SARS-CoV-2 antibody; COVID-19; SARS-CoV-2 vaccine.

PubMed Disclaimer

Comment on

References

    1. Funakoshi Y, Yakushijin K, Ohji G, Hojo W, Sakai H, Watanabe M, et al. Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibody. Int J Hematol. 2022;115:7–10. doi: 10.1007/s12185-021-03247-y. - DOI - PMC - PubMed
    1. Hagihara M, Ohara S, Uchida T, Inoue M. Practical management of patients with hematological diseases during the COVID-19 pandemic in Japan. Int J Hematol. 2021;114:709–718. doi: 10.1007/s12185-021-03175-x. - DOI - PMC - PubMed
    1. Perry C, Luttwak E, Balaban R, Shefer G, Morales MM, Aharon A, et al. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma. Blood Adv. 2021;5:3053–3061. doi: 10.1182/bloodadvances.2021005094. - DOI - PMC - PubMed